| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 43 | 255 | 383 | 106 | 22 | 270 | 395 | 129 | 1,603 |
| - | - | 2 | 124 | 189 | 6 | 1 | 33 | 78 | 28 | 461 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 1,603 | 99.5% | -1.80 | 461 | 100.0% |
| Optic-unspecified(R) | 8 | 0.5% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Mi20 | % In | CV |
|---|---|---|---|---|---|
| Tm3 (R) | 51 | ACh | 190 | 12.0% | 0.8 |
| Pm3 (R) | 9 | GABA | 122 | 7.7% | 0.6 |
| L5 (R) | 74 | ACh | 118 | 7.5% | 0.5 |
| Dm13 (R) | 7 | GABA | 109 | 6.9% | 1.0 |
| Mi10 (R) | 28 | ACh | 99 | 6.3% | 0.6 |
| TmY10 (R) | 31 | ACh | 98 | 6.2% | 0.9 |
| Mi4 (R) | 51 | GABA | 90 | 5.7% | 0.6 |
| Cm2 (R) | 20 | ACh | 69 | 4.4% | 0.5 |
| Mi9 (R) | 40 | Glu | 60 | 3.8% | 0.6 |
| TmY5a (R) | 40 | Glu | 57 | 3.6% | 0.5 |
| T2a (R) | 28 | ACh | 49 | 3.1% | 0.5 |
| Mi1 (R) | 22 | ACh | 44 | 2.8% | 0.7 |
| Tm1 (R) | 18 | ACh | 34 | 2.2% | 0.6 |
| T2 (R) | 24 | ACh | 33 | 2.1% | 0.7 |
| MeLo9 (R) | 5 | Glu | 28 | 1.8% | 0.8 |
| Tm4 (R) | 15 | ACh | 27 | 1.7% | 0.6 |
| Pm9 (R) | 7 | GABA | 26 | 1.6% | 0.5 |
| TmY9b (R) | 6 | ACh | 24 | 1.5% | 1.3 |
| MeLo8 (R) | 6 | GABA | 24 | 1.5% | 1.0 |
| Pm2a (R) | 11 | GABA | 19 | 1.2% | 0.5 |
| Tm20 (R) | 10 | ACh | 18 | 1.1% | 0.8 |
| Tm5a (R) | 9 | ACh | 18 | 1.1% | 0.6 |
| Tm2 (R) | 14 | ACh | 18 | 1.1% | 0.5 |
| Pm2b (R) | 8 | GABA | 17 | 1.1% | 0.5 |
| Dm10 (R) | 15 | GABA | 15 | 1.0% | 0.0 |
| Tm5Y (R) | 8 | ACh | 13 | 0.8% | 0.5 |
| MeLo1 (R) | 6 | ACh | 13 | 0.8% | 0.3 |
| Dm20 (R) | 9 | Glu | 13 | 0.8% | 0.5 |
| TmY14 (R) | 9 | unc | 12 | 0.8% | 0.7 |
| Dm2 (R) | 8 | ACh | 11 | 0.7% | 0.7 |
| Cm11d (R) | 3 | ACh | 9 | 0.6% | 0.5 |
| Dm8a (R) | 4 | Glu | 7 | 0.4% | 0.5 |
| TmY3 (R) | 6 | ACh | 7 | 0.4% | 0.3 |
| Cm31a (R) | 2 | GABA | 6 | 0.4% | 0.3 |
| Pm4 (R) | 4 | GABA | 6 | 0.4% | 0.6 |
| LC14b (L) | 3 | ACh | 5 | 0.3% | 0.3 |
| Mi18 (R) | 4 | GABA | 5 | 0.3% | 0.3 |
| MeVP41 (R) | 1 | ACh | 4 | 0.3% | 0.0 |
| Pm10 (R) | 2 | GABA | 4 | 0.3% | 0.5 |
| TmY15 (R) | 3 | GABA | 4 | 0.3% | 0.4 |
| L4 (R) | 4 | ACh | 4 | 0.3% | 0.0 |
| MeLo14 (R) | 1 | Glu | 3 | 0.2% | 0.0 |
| MeVPMe1 (L) | 1 | Glu | 3 | 0.2% | 0.0 |
| DNc01 (L) | 1 | unc | 3 | 0.2% | 0.0 |
| L3 (R) | 2 | ACh | 3 | 0.2% | 0.3 |
| Cm11b (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeLo13 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVC25 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| Cm1 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm5b (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm31 (R) | 2 | GABA | 2 | 0.1% | 0.0 |
| TmY21 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm38 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| Pm8 (R) | 2 | GABA | 2 | 0.1% | 0.0 |
| Tm6 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC9 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Mi2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Tm29 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| TmY18 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm9 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Mi14 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Tm40 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm7 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Tm26 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Y3 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Y14 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP3 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Y13 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LT88 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe17c (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LPT54 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm34 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPMe1 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns Mi20 | % Out | CV |
|---|---|---|---|---|---|
| TmY3 (R) | 68 | ACh | 369 | 21.0% | 0.7 |
| Tm2 (R) | 100 | ACh | 293 | 16.7% | 0.6 |
| Dm10 (R) | 51 | GABA | 224 | 12.8% | 0.7 |
| Tm1 (R) | 39 | ACh | 90 | 5.1% | 0.6 |
| Pm2a (R) | 13 | GABA | 69 | 3.9% | 0.7 |
| Mi1 (R) | 41 | ACh | 68 | 3.9% | 0.5 |
| Dm13 (R) | 7 | GABA | 65 | 3.7% | 0.7 |
| Mi9 (R) | 41 | Glu | 57 | 3.2% | 0.5 |
| Dm12 (R) | 18 | Glu | 43 | 2.4% | 0.6 |
| Mi4 (R) | 32 | GABA | 40 | 2.3% | 0.3 |
| Mi14 (R) | 18 | Glu | 39 | 2.2% | 0.4 |
| MeLo8 (R) | 6 | GABA | 28 | 1.6% | 1.0 |
| Pm3 (R) | 7 | GABA | 24 | 1.4% | 0.6 |
| Tm4 (R) | 19 | ACh | 24 | 1.4% | 0.4 |
| Pm4 (R) | 11 | GABA | 23 | 1.3% | 0.6 |
| Tm3 (R) | 20 | ACh | 23 | 1.3% | 0.3 |
| Mi18 (R) | 8 | GABA | 22 | 1.3% | 0.8 |
| MeLo3a (R) | 8 | ACh | 22 | 1.3% | 0.7 |
| T2 (R) | 17 | ACh | 22 | 1.3% | 0.4 |
| Pm12 (R) | 2 | GABA | 17 | 1.0% | 0.4 |
| MeLo9 (R) | 5 | Glu | 15 | 0.9% | 0.4 |
| T2a (R) | 12 | ACh | 15 | 0.9% | 0.3 |
| TmY5a (R) | 14 | Glu | 15 | 0.9% | 0.2 |
| TmY14 (R) | 10 | unc | 14 | 0.8% | 0.5 |
| Mi10 (R) | 11 | ACh | 14 | 0.8% | 0.3 |
| TmY18 (R) | 10 | ACh | 10 | 0.6% | 0.0 |
| TmY13 (R) | 10 | ACh | 10 | 0.6% | 0.0 |
| Lawf1 (R) | 7 | ACh | 9 | 0.5% | 0.4 |
| MeVPMe12 (R) | 2 | ACh | 6 | 0.3% | 0.7 |
| DNc01 (L) | 1 | unc | 5 | 0.3% | 0.0 |
| MeLo7 (R) | 4 | ACh | 5 | 0.3% | 0.3 |
| MeLo3b (R) | 4 | ACh | 5 | 0.3% | 0.3 |
| Pm5 (R) | 4 | GABA | 5 | 0.3% | 0.3 |
| Y3 (R) | 5 | ACh | 5 | 0.3% | 0.0 |
| Tm38 (R) | 3 | ACh | 4 | 0.2% | 0.4 |
| Pm2b (R) | 3 | GABA | 4 | 0.2% | 0.4 |
| MeVPMe2 (R) | 3 | Glu | 4 | 0.2% | 0.4 |
| L4 (R) | 4 | ACh | 4 | 0.2% | 0.0 |
| MeVP4 (R) | 4 | ACh | 4 | 0.2% | 0.0 |
| T3 (R) | 3 | ACh | 3 | 0.2% | 0.0 |
| Tm6 (R) | 3 | ACh | 3 | 0.2% | 0.0 |
| TmY21 (R) | 3 | ACh | 3 | 0.2% | 0.0 |
| Mi17 (R) | 2 | GABA | 2 | 0.1% | 0.0 |
| Tm12 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm5Y (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPMe2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| L5 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeLo2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm20 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm36 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| TmY9a (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| L1 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Tm26 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Dm8a (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Tm31 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| TmY10 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Y14 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeLo12 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Pm10 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Pm8 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeLo13 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Dm20 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm19 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Pm9 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP17 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Pm13 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPMe1 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP53 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| DNp30 (L) | 1 | Glu | 1 | 0.1% | 0.0 |